Physician profile
Echo L Mills
NPI 1285181255
$2,934.21
in general payments reported to CMS, 2019-2025
12 companies · $2,248 in 2025
The $2,248 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $399 · 2023: $55.41 · 2024: $231 · 2025: $2,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,488 · Travel and Lodging: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,488.12 |
| Travel and Lodging | $1,046.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,414.93 | 2025 | |
| Titan Surgical Group, LLC | $808.95 | 2021-2025 | |
| Medtronic, INC. | $295.60 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Abbvie INC. | $190.09 | 2023-2024 | |
| Acumed LLC | $41.36 | 2025 | Acumed |
| Stryker Corporation | $40.69 | 2025 | Aequalis Ascend Flex |
| Bioventus LLC | $31.83 | 2023-2025 | Durolane, Xcell |
| Depuy Synthes Sales INC. | $30.84 | 2025 | Motoband, Na |
| Nevro Corp. | $26.43 | 2024 | Senza |
| Pacira Therapeutics, INC. | $22.81 | 2021 | |
| Endo Pharmaceuticals INC. | $16.73 | 2021 | |
| Amgen INC. | $13.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Echo Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.